Dr. Renée J. G. Arnold

President & CEO

Renée J. Goldberg Arnold completed her undergraduate training at the University of Maryland and received her Doctor of Pharmacy from the University of Southern California in LA.  Dr. Arnold is currently President and CEO, Arnold Consultancy & Technology LLC, NYC, where she develops and oversees outcomes research and affiliated software for industry and federal government.  Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational healthcare decision-making by healthcare practitioners and policy makers. 


Dr. Arnold's academic titles include Full Adjunct Professor, Div. of Social Sciences, at LIU, including as a preceptor for students completing rotations in health outcomes and pharmacoeconomics.  She is also Adjunct Associate Professor, Master of Public Health program, Department of Community and Preventive Medicine at the Mount Sinai School of Medicine, where she has developed the pharmacoeconomics coursework and is a preceptor for MD/MPH students completing their MPH practicums. 


Dr. Arnold also initiated internship and post-doctoral fellowship programs in pharmacoeconomics at Arnold Consultancy & Technology LLC and is a founding member and former Chair of the Education Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), as well as current Chair of the Disease/Health Management Working Group of the ISPOR Health Care Decisions Using Outcomes Research Special Interest Group (HCDUOR).  In addition, she is a licensed pharmacist.  Dr. Arnold is the author of numerous articles in the areas of pharmacology, pharmacoeconomics and cost containment strategies and is a co-author of four book chapters, one in cardiovascular therapeutics, another in pharmacoeconomic analyses in cardiovascular disease, the third in computer applications in pharmaceutical research and development and the fourth in quality of life and cost of atopic dermatitis.  Lastly, she has written a book entitled "Introduction to Pharmacoeconomics - from theory to practice".

Click on the icon below to view her full CV:


Arnold R. Introduction to Pharmacoeconomics: From Theory to Practice. Boca Raton Taylor and Francis Group, LLC, 2009 (in press).

Arnold RJG, Kuan RK.  Quality of life and costs in atopic dermatitis.  In: Preedy VR, Watson, RR (eds).  Handbook of Disease Burdens and Quality of Life Measures. Heidelberg: Springer; 2008.

Marcus P, Arnold RJG, Ekins S, et al.  A Retrospective Randomized Study of Asthma Control in the US: Results of the CHARIOT Study; Current Medical Research and Opinion 2008;24:3443-3452.


Cheng JWM, Arnold RJG.  Pharmacoeconomic Review of Medical Management of Persistent Asthma.  Allergy and Asthma Proceedings 2008 (March-April);29(2).


Arnold RJG. Cost-Effectiveness Analysis:  Should It Be Required for Drug Registration and Beyond?  Drug Discov Today 2007; Vol 12/21-22: 960-965.

Arnold RJG, Donnelly A, Altieri L, Wong KS, Sung J.  Assessment of outcomes and parental impact on quality of life endpoints in the management of atopic dermatitis (ATOPIQUE) Managed Care Interface 2007;20:18-23.


Arnold R. Use of interactive software in medical decision making. In: Ekins S, ed. Computer Applications in Pharmaceutical Research and Development. Hoboken: John Wiley & Sons, Inc.; 2006.

Arnold RJG, Kim R, Tang B.  The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia:  the effect of early versus delayed treatment.  Cardiol Rev 2006;14:7-13. 

Arnold RJG, Gabrail N, Raut M, Kim R, Sung JCY, Zhou Y.  Clinical implications of chemotherapy-induced diarrhea in patients with cancer.  Journal of Supportive Oncology 2005 May-Jun;3(3):227-32. 

Arnold RJG, Gabrail N, Raut M, Kim R, Zhou Y.  Implications of Chemotherapy-induced Diarrhea on Dosing Intensity.  Journal of Clinical Oncology 2004;22(14S):6128.

Arnold RJ, Kaniecki DJ, Rosen J.  Web-enabled asthma application for personalized medical communication within a multi-group practice setting.  Value in Health 2004; 7: 310 (abstract).

Arnold RJ, Gabrail N, Raut M, Kim R, Sung J, Gause D, Zhou Y.  Impact of chemotherapy-induced diarrhea on management patterns and resource utilization among cancer patients: results from a multi-site study.  Value in Health 2004; 7: 246 (abstract).

Fischer J, Arnold RJG, Kaniecki DJ, O'Neill C, Dirani RG.  The Avandia Worldwide Awareness Registry (AWARe®) Use of the EB Health server Internet analysis tools: an internet-based program for real-time evaluation of clinical, humanistic and economic outcomes of patients.  63rd Scientific Sessions Abstract Book of the American Diabetes Association 2003, the June supplement to Diabetes.

Raut M, Arnold R, Kim R, Sung J, Law A, Siegel N.  Chemotherapy-induced diarrhea treatment and resource utilization study: a study overview.   Proc Am Soc Clin Oncol 2003;22 (abstr 2221).


Goldberg Arnold RJ, Kaniecki DJ.  Health economic considerations in cardiovascular drug utilization. In: Frishman WH, Sonnenblick EH, ed. Cardiovascular Pharmacotherapeutics. 2nd Edition. New York: McGraw Hill, Inc., 2003. 43.

Fivenson D, Arnold RJG, Kaniecki DJ, Cohen JL, Frech F, Finlay A.  The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization.  Jnl Mgd Care Pharm 2002;8:333-342.

Najib MM, Arnold RJG, Kaniecki DJ, Pettit KG, Roth D, Antell L, Xuan J.  Medical resource use and costs of congestive heart failure following use of carvedilol.  Heart Disease 2002 March/April;4:70-77.

Bree RL, Arnold RJG, Pettit KG, Kaniecki DJ, LaFrance ND, Lev Toaff A.  Use of decision analytic methodology to support use of a new oral ultrasound contrast agent for patients with abdominal pain.  Acad Radiol 2001;8:234-242.


Goldberg Arnold RJ.  Disease management and pharmacoeconomics as tools for mass prevention of hypertensive complications.  Heart Disease 2000 May/June 2001:3;152-156.

Zaman A, Goldberg Arnold RJ, Pettit KG, Kaniecki DJ, Benner K, Zacker C, DiCesare J, Helfand M.  Cost of Treating an Episode of Variceal Bleeding in a VA Setting. Am J Gastroenterol. 2000;95:1323-1330.

Arnold RJG, Akhras KS, Chen C, Chen S, Pettit KG, Kaniecki DJK.  Review of the Development, Validation and Application of Predictive Instruments in Interventional Cardiology.  Heart Disease July/August, 1999;1(3):138-148.